EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Baxdrostat as a catalyst for precision hypertension: integrating pharmacogenomics, omics biomarkers, and digital phenotyping in resistant hypertension management

Asra Amjad iD, Syeda Tayyaba Batool iD, Umair Ali iD

Clinical Hypertension · 2026 · 32 (1)

DOI: 10.5646/ch.2026.32.e27 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Hypertension, 2026. Verfasst von Asra Amjad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan.
  • Azad Jammu and Kashmir Medical College, Muzaffarabad, Pakistan.
  • Department of Pharmacy, University of Swabi, Swabi, Pakistan.

ORCID-Profile: Asra Amjad, Syeda Tayyaba Batool, Umair Ali

Zitieren

APA

Amjad, A., Batool, S. T., & Ali, U. (2026). Baxdrostat as a catalyst for precision hypertension: integrating pharmacogenomics, omics biomarkers, and digital phenotyping in resistant hypertension management. Clinical Hypertension, 32(1). https://doi.org/10.5646/ch.2026.32.e27

Vancouver

Amjad A, Batool ST, Ali U. Baxdrostat as a catalyst for precision hypertension: integrating pharmacogenomics, omics biomarkers, and digital phenotyping in resistant hypertension management. Clinical Hypertension. 2026;32(1). doi:10.5646/ch.2026.32.e27

BibTeX
@article{Amjad2026,
  author = {Amjad, Asra and Batool, Syeda Tayyaba and Ali, Umair},
  title = {Baxdrostat as a catalyst for precision hypertension: integrating pharmacogenomics, omics biomarkers, and digital phenotyping in resistant hypertension management},
  journal = {Clinical Hypertension},
  year = {2026},
  volume = {32},
  number = {1},
  doi = {10.5646/ch.2026.32.e27}
}
Kostenlos starten →